Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-03

Clinical Trial Update: FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI [Phase 2]

View source ↗

Summary

Phase 2 trial comparing fecal microbiota transplant to antimicrobials for initial treatment of recurrent Clostridium difficile infection; study terminated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplant (fecal microbiota transplant)
  • antimicrobials

Snippet

Sponsor: Endeavor Health | Conditions: Clostridium Difficile Infection | Phase 2 | Status: TERMINATED | Results posted: 2023-03-03